NOVARTIS PHARMACEUTICALS CORP has a total of 14 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are BERINGER INGEL GEJM KG, VERTEKS FARMASYUTIKALZ INKORPOREJTED and ASKAT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Packaging and shipping | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Dowdell Verity | 3 |
#2 | Carter Malcolm | 3 |
#3 | Henderson Elisa | 3 |
#4 | Danville David Roy | 2 |
#5 | Stankovic Miona | 2 |
#6 | Cooper Nichola | 2 |
#7 | Zaja Francesco | 2 |
#8 | Alber Dagmar | 2 |
#9 | Kelsey Richard | 2 |
#10 | Ghanima Waleed | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020231407A1 | Eltrombopag dosing regimen | |
WO2020231408A1 | Eltrombopag dosing regimen | |
US6211384B1 | Methods for the acylation of amine compounds | |
US6230894B1 | Child resistant package and method of dispensing medication | |
AU6167794A | Human monoclonal antibodies to cytomegalovirus | |
US5753675A | Quinoline analogs of mevalonolactone and derivatives thereof |